Pharmafile - Medical Communications News
Hackers suspected to be operating from North Korea have tried to break into the systems of AstraZeneca, two people with knowledge of the event told...
This is the pair’s second successful Japanese approval for the drug, which is already available in the country for the treatment of anaemia of CKD in...
AstraZeneca is expected to launch new global trials to assess the efficacy of its COVID-19 vaccine using a lower dosage.
The European Union has fined Teva and Cephalon for colluding to keep a cheap alternative sleep disorder medicine off the market.
The top ten news stories this week once again focus on COVID-19 treatments, with the Canadian Government securing 26,000 doses of Eli Lilly’s...
Besides the latest vaccine and industry news, the new issue also includes features on the diabetes space and how it has been affected by the COVID-19...
The World Health Organization does not recommend using Gilead’s antiviral drug remdesivir to treat hospitalised COVID-19 patients, no matter how...
Eli Lilly has entered into a global non-exclusive agreement with Ypsomed for the advancement of an automated insulin delivery system for people with...
The move comes only two days after the release of the final analysis data. Applications to other worldwide regulators will swiftly follow,...
The candidate demonstrated non-inferiority to standard-dose, egg-based quadrivalent-inactivated influenza vaccines in terms of immunogenicity,...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
